Loading insider details...
Beta
Latest Form 4 (Jan 23, 2026): Disposition to Issuer of 16,666 ATXS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 16,666 | n/a |
| Jun 12, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 26,550 | n/a |
| Jun 6, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |
| Jan 24, 2024 | Orchard Therapeutics plc (ORTX) | Disposition to Issuer | 9,294 | n/a |
| Jun 6, 2023 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |
| Jun 9, 2022 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 8,333 | n/a |
| Jun 2, 2021 | CATABASIS PHARMACEUTICALS INC (CATB) | Grant/Award | 100,000 | n/a |
| Jun 12, 2020 | CATABASIS PHARMACEUTICALS INC (CATB) | Grant/Award | 7,500 | n/a |